Your dog was diagnosed with Transmissible Venereal Tumour (TVT). Sexually transmitted canine tumour with unique biology — naturally transplantable allogeneic cancer. Endemic globally in at least 90 countries but rare in the US, Canada, and Northern Europe. Common in regions with free-roaming dog populations. In the US, primarily seen in imported dogs or dogs from border regions. Compare 2 treatment options for dogs including Vincristine Monotherapy, Surgical Excision — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Transmissible Venereal Tumour (TVT)
Canine Oncology Treatment Guide
Transmissible Venereal Tumour (TVT)
Round Cell
About This Cancer
Transmissible venereal tumour (TVT) is biologically unique among all known cancers — it is a naturally transmissible cancer spread between dogs through direct contact, typically during mating. The tumour cells themselves are the infectious agent, transferred from one dog to another as living cells, much like a transplant. Remarkably, all TVT cells worldwide descend from a single dog that lived thousands of years ago, making this one of the oldest known cell lines. The tumour most commonly appears on the genital mucosa as a fleshy, cauliflower-like growth, though it can occasionally appear at other sites such as the nose or mouth. TVT is endemic in many tropical and subtropical countries with free-roaming dog populations but rare in countries with effective stray-dog control. The disease responds remarkably well to chemotherapy with vincristine, which is curative in the vast majority of cases.
Prognostic Factors(1)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.